Revealed: How the Sackler family’s opioid empire continues to make hundreds of millions of dollars in profits around the world

Finance Uncovered conducts forensic analysis of Mundipharma financials for global investigation

A collaboration of journalists from eight countries has today published an investigation into the international pharmaceutical businesses ultimately owned by the Sacklers, the family behind the OxyContin prescription painkiller that became emblematic of the early phase of the U.S. opioid crisis, which has killed hundreds of thousands of Americans.

It reveals how even though the Sacklers’ U.S. business unit, Purdue Pharma, declared bankruptcy in 2019, the family’s broader drugs empire in 120 countries has continued to sell massive quantities of pain pills, raking in hundreds of millions of dollars in profits.

The World of Pain investigation comes at a critical juncture for lawyers trying to pressure the Sacklers into handing over billions of dollars—made when Purdue was highly profitable—to victims ravaged by America’s opioid epidemic. U.S. courts have set a deadline of September 27, by which the Sacklers must settle negotiations to stave off the threat of lawsuits, many alleging the family illegally profiteered from the opioid crisis. (Finance Uncovered, USA, 24.09.2025)

https://www.financeuncovered.org/stories/mundipharma-profits-worldwide-financial-analysis-sacklers